Joseph Michael Casper
CIK: 0002106955
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRXP
NRX Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Casper Joseph Michael
Casper Joseph Michael (SEC CIK 0002106955) files insider reports with the SEC as Chief Operating Officer of NRX Pharmaceuticals, Inc. (NRXP).
Signal8 holds 2 ownership filings by Casper Joseph Michael (1 Form 3, 1 Form 4), filed on Feb 17, 2026. Those filings report 1 transaction, the latest on Jan 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Casper Joseph Michael's filings is in WILMINGTON, DE.
Recent filings by Casper Joseph Michael
- Jan 27, 2026: Grant or award of NRXP derivative securities (Form 4, code A).
Other insiders filing for NRX Pharmaceuticals, Inc. (NRXP)
- Javitt Jonathan C, Chairman and Chief Scientist
- McBride Dennis, Director
- Hurvitz Chaim, Director
- Flynn Patrick John, Director
- B Group, Inc., 10% Owner
- ABRAMS MICHAEL S, Chief Financial Officer